Two years after becoming an independent company, Solventum is doubling down on Minnesota with a major investment in innovation—one that state leaders say reinforces the region’s status as a global medtech hub.

On Wednesday, the Fortune 500 company celebrated both its second anniversary and the opening of a new $200 million research and development facility in Eagan. The 250,000-square-foot hub brings together the full breadth of Solventum’s work—from medical-surgical supplies to digital health systems—under one roof for the first time.

“This building is like the Taj Mahal,” said CEO Bryan Hanson at the opening event. “This is where the ideation and innovation happens.”

Solventum largely funded the facility itself, with approximately $13 million in support from the state through the Job Creation Fund and Minnesota Investment Fund. Inside the building are advanced lab and production development spaces, along with more than 400 desks dedicated to training and collaboration across departments.

When 3M announced in 2022 it would spin off its health care business into a separate company, there were concerns the newly formed entity might leave Minnesota. Instead, Solventum chose to deepen its roots.

Gov. Tim Walz marked the occasion by proclaiming April 1 as Solventum Day, praising the company’s decision to stay.

“When Bryan came in, people thought Solventum wouldn’t stick around,” Walz explained. “Bryan, and all the employees, wanted to stay in Minnesota, and that means a lot.”

That decision carries economic weight, as Solventum employs over 1,800 people in Minnesota. No additional hires are expected at the new facility. The company maintains additional operations in Eden Prairie and Oakdale, which include manufacturing for patient warming devices and a repair center for electronic medical equipment, respectively.

Sen. Amy Klobuchar framed the expansion as part of broader momentum in Minnesota’s business climate.

“We’re going up because of the people in this room,” she said, also mentioning Pivot Bio, a fertilizer company that recently moved to Minnetonka from California.

Globally, Solventum employs more than 20,000 people across 39 countries and reported $8.25 billion in revenue in 2025, ranking No. 462 on the Fortune 500. The company specializes in advanced wound care, infection prevention, dental products, and health information systems—areas Hanson says will be accelerated by the R&D hub in Eagan.

“This is where everything comes together,” he added.